X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://endpts.com/kyowa-kirin-brings-rare-disease-drugs-marketing-back-in-house-plots-future-us-growth/
https://www.globenewswire.com/news-release/2022/07/14/2479715/20739/en/Ultragenyx-Announces-Sale-of-a-Portion-of-Future-North-American-Royalties-on-Crysvita-burosumab-for-500-Million-to-OMERS-Capital-Markets.html
https://www.globenewswire.com/news-release/2021/09/27/2303972/20739/en/Ultragenyx-Announces-Crysvita-burosumab-and-UX143-setrusumab-Data-Presentations-at-Upcoming-American-Society-for-Bone-and-Mineral-Research-ASBMR-2021-Annual-Meeting.html
https://www.pharmatimes.com/news/new_data_demonstrates_long-term_benefit_of_crysvita_for_xlh_patients_1379158
https://www.businesswire.com/news/home/20210924005094/en/Long-Term-CRYSVITA%C2%AE-%E2%96%BC-burosumab-Treatment-Reduces-the-Burden-of-Disease-in-Adults-With-X-Linked-Hypophosphataemia-XLH-a-Rare-Genetic-Metabolic-Bone-Disease
https://www.globenewswire.com/news-release/2021/09/07/2292414/20739/fr/NOTE-AUX-M%C3%89DIAS-Ultragenyx-Canada-annonce-l-approbation-par-Sant%C3%A9-Canada-d-une-deuxi%C3%A8me-indication-du-Crysvita-injection-de-burosumab-pour-le-traitement-de-l-ost%C3%A9omalacie-oncog%C3%A9niq.html
http://www.pharmatimes.com/news/kyowa_kirins_crysvita_wins_eu_approval_for_expanded_xlh_population_1352480
http://www.pharmatimes.com/news/kyowa_kirins_crysvita_wins_eu_approval_for_expanded_xlh_population_1352480
http://www.pharmatimes.com/news/chmp_backs_expanding_scope_of_kyowa_kirins_crysvita_1345712
https://www.businesswire.com/news/home/20200724005256/en/Kyowa-Kirin-Receives-Positive-CHMP-Opinion-Expanded
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761068
https://www.raps.org/news-and-articles/news-articles/2020/6/fda-round
https://www.prnewswire.com/news-releases/fda-approves-first-therapy-for-rare-disease-that-causes-low-phosphate-blood-levels-bone-softening-301079748.html
http://www.pharmafile.com/news/541764/scottish-medicines-consortium-enables-access-treatment-rare-inherited-bone-disorder-chil
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761068
http://www.pharmatimes.com/news/xlh_patients_to_get_routine_access_to_first_new_therapy_in_30_years_1255141
http://www.pharmatimes.com/news/nice_u-turn_approves_funding_for_rare_disease_therapy_crysvita_1251387
Market Place
Share 
